Spots Global Cancer Trial Database for bleomycin sulfate
Every month we try and update this database with for bleomycin sulfate cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease | NCT00000626 | HIV Infections Hodgkin's Disea... | Vinblastine sul... Dacarbazine Filgrastim Bleomycin sulfa... Doxorubicin hyd... | 12 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease | NCT00004010 | Lymphoma | bleomycin sulfa... filgrastim ABVD regimen cyclophosphamid... dacarbazine doxorubicin hyd... etoposide prednisone procarbazine hy... vinblastine sul... vincristine sul... radiation thera... | - 21 Years | Children's Oncology Group | |
| Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer | NCT00003941 | Mediastinal Can... Metastatic Canc... Testicular Germ... | bleomycin sulfa... filgrastim cisplatin etoposide ifosfamide bone marrow abl... peripheral bloo... | 16 Years - 50 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| A Study of Chemotherapy Plus Azidothymidine in the Treatment of Kaposi's Sarcoma in Patients With AIDS | NCT00000987 | Sarcoma, Kaposi HIV Infections | Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Zidovudine | 13 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors | NCT00066482 | Childhood Germ ... Extragonadal Ge... | bleomycin sulfa... filgrastim cisplatin cyclophosphamid... etoposide conventional su... MESNA | - 21 Years | Children's Oncology Group | |
| Study of a-Interferon With Adriamycin, Bleomycin, Velban, and Dacarbazine (ABVD) With Hodgkin's Disease | NCT01404936 | Lymphoma | Interferon-2A Adriamycin Bleomycin Velban Dacarbazine | - | M.D. Anderson Cancer Center | |
| Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors | NCT00274950 | Childhood Germ ... Extragonadal Ge... Ovarian Cancer | bleomycin sulfa... carboplatin cisplatin etoposide ifosfamide vinblastine sul... adjuvant therap... conventional su... | - 17 Years | National Cancer Institute (NCI) | |
| Study of a-Interferon With Adriamycin, Bleomycin, Velban, and Dacarbazine (ABVD) With Hodgkin's Disease | NCT01404936 | Lymphoma | Interferon-2A Adriamycin Bleomycin Velban Dacarbazine | - | M.D. Anderson Cancer Center | |
| Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testicles | NCT00324298 | Drug/Agent Toxi... Testicular Germ... | bleomycin sulfa... cisplatin etoposide management of t... | 18 Years - 50 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease | NCT00002714 | Lymphoma | bleomycin sulfa... Stanford V regi... doxorubicin hyd... etoposide mechlorethamine... prednisone vinblastine sul... vincristine sul... radiation thera... | 16 Years - 60 Years | National Cancer Institute (NCI) | |
| Rituximab and ABVD for Hodgkin's Patients | NCT00504504 | Lymphoma | Rituximab Adriamycin Bleomycin Vinblastine Dacarbazine (DT... | 16 Years - | M.D. Anderson Cancer Center | |
| Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors | NCT01042522 | Ovarian Granulo... Ovarian Gynandr... Ovarian Sertoli... Ovarian Sex Cor... Ovarian Sex Cor... Ovarian Sex Cor... Ovarian Steroid... | Bleomycin Sulfa... Carboplatin Cisplatin Etoposide Phosp... Laboratory Biom... Paclitaxel | 18 Years - | GOG Foundation | |
| Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members | NCT00000703 | Lymphoma, Non-H... HIV Infections | Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Cyclophosphamid... Allopurinol Methotrexate Cytarabine Leucovorin calc... Zidovudine Dexamethasone | 19 Years - 69 Years | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma. | NCT00002093 | Sarcoma, Kaposi HIV Infections | Daunorubicin (l... Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... | 18 Years - | NIH AIDS Clinical Trials Information Service | |
| Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma | NCT00002565 | Lymphoma | bleomycin sulfa... CHOP regimen cisplatin cyclophosphamid... cytarabine doxorubicin hyd... etoposide idarubicin ifosfamide mesna methylprednisol... mitoxantrone hy... prednisone vincristine sul... | 15 Years - | M.D. Anderson Cancer Center | |
| A Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's Sarcoma | NCT00002318 | Sarcoma, Kaposi HIV Infections | Doxorubicin hyd... Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... | 18 Years - | NIH AIDS Clinical Trials Information Service | |
| Combination Chemotherapy in Treating Male Patients With Germ Cell Tumors | NCT00301782 | Extragonadal Ge... Teratoma Testicular Germ... | bleomycin sulfa... carboplatin cisplatin etoposide phosp... vincristine sul... | 16 Years - | National Cancer Institute (NCI) | |
| Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma | NCT00000689 | Lymphoma, Non-H... HIV Infections | Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Cyclophosphamid... Methotrexate Cytarabine Leucovorin calc... Sargramostim Dexamethasone | 13 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma | NCT00003815 | Lymphoma | bleomycin sulfa... carmustine cyclophosphamid... cytarabine doxorubicin hyd... etoposide melphalan prednisolone vincristine sul... autologous bone... radiation thera... | 15 Years - 65 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma | NCT00005867 | Lymphoma | bleomycin sulfa... CHOP regimen cyclophosphamid... doxorubicin hyd... etoposide mitoxantrone hy... prednisolone vincristine sul... | 18 Years - 59 Years | National Cancer Institute (NCI) | |
| Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors | NCT01042522 | Ovarian Granulo... Ovarian Gynandr... Ovarian Sertoli... Ovarian Sex Cor... Ovarian Sex Cor... Ovarian Sex Cor... Ovarian Steroid... | Bleomycin Sulfa... Carboplatin Cisplatin Etoposide Phosp... Laboratory Biom... Paclitaxel | 18 Years - | GOG Foundation | |
| Rituximab and ABVD for Hodgkin's Patients | NCT00504504 | Lymphoma | Rituximab Adriamycin Bleomycin Vinblastine Dacarbazine (DT... | 16 Years - | M.D. Anderson Cancer Center | |
| Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma | NCT01026220 | Childhood Nodul... Stage III Child... Stage IV Childh... | bleomycin sulfa... doxorubicin hyd... liposomal vincr... vinorelbine tar... cyclophosphamid... etoposide phosp... prednisone filgrastim ifosfamide | - 21 Years | Children's Oncology Group | |
| Rituximab and Combination Chemotherapy With or Without Bleomycin Sulfate in Treating Patients With Primary Mediastinal Large B-Cell Lymphoma | NCT00983944 | Lymphoma | bleomycin sulfa... rituximab EPOCH regimen cyclophosphamid... doxorubicin hyd... etoposide prednisone vincristine sul... | 10 Years - | Ohio State University Comprehensive Cancer Center | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease | NCT00002714 | Lymphoma | bleomycin sulfa... Stanford V regi... doxorubicin hyd... etoposide mechlorethamine... prednisone vinblastine sul... vincristine sul... radiation thera... | 16 Years - 60 Years | National Cancer Institute (NCI) | |
| A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab | NCT05675410 | Lugano Classifi... | Biospecimen Col... Bleomycin Sulfa... Brentuximab Ved... Computed Tomogr... Cyclophosphamid... Dacarbazine Doxorubicin Hyd... Etoposide Etoposide Phosp... Fludeoxyglucose... Involved-site R... Magnetic Resona... Nivolumab Positron Emissi... Prednisolone Prednisone Procarbazine Hy... Questionnaire A... Vinblastine Sul... Vincristine Sul... | 5 Years - 60 Years | National Cancer Institute (NCI) | |
| A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years | NCT00079105 | Lymphoma | bleomycin sulfa... cyclophosphamid... etoposide mitoxantrone hy... prednisolone procarbazine hy... vinblastine sul... | 60 Years - 120 Years | Newcastle-upon-Tyne Hospitals NHS Trust | |
| Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma | NCT02166463 | Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Childhood Hodgk... Classic Hodgkin... | Bleomycin Sulfa... Brentuximab Ved... Cyclophosphamid... Doxorubicin Hyd... Etoposide Laboratory Biom... Methylprednisol... Pharmacological... Prednisone Quality-of-Life... Questionnaire A... Vincristine Sul... | 2 Years - 22 Years | National Cancer Institute (NCI) | |
| S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma | NCT00822120 | Lymphoma Nonneoplastic C... | bleomycin sulfa... filgrastim ABVD regimen BEACOPP regimen cyclophosphamid... dacarbazine doxorubicin hyd... etoposide prednisone procarbazine hy... vinblastine sul... vincristine sul... | 18 Years - 60 Years | SWOG Cancer Research Network | |
| Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer | NCT00002476 | Head and Neck C... | bleomycin sulfa... fluorouracil leucovorin calc... methotrexate vincristine sul... low-LET cobalt-... low-LET photon ... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members | NCT00000703 | Lymphoma, Non-H... HIV Infections | Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Cyclophosphamid... Allopurinol Methotrexate Cytarabine Leucovorin calc... Zidovudine Dexamethasone | 19 Years - 69 Years | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Combination Chemotherapy in Treating Men With Germ Cell Cancer | NCT00003643 | Extragonadal Ge... Teratoma Testicular Germ... | bleomycin sulfa... filgrastim cisplatin etoposide paclitaxel | 16 Years - 50 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma | NCT00000681 | Sarcoma, Kaposi HIV Infections | Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Zidovudine Sargramostim | 14 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma | NCT00000658 | Lymphoma, Non-H... HIV Infections | Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Cyclophosphamid... Allopurinol Methotrexate Cytarabine Leucovorin calc... Sargramostim Dexamethasone | 12 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Rituximab and ABVD for Hodgkin's Patients | NCT00504504 | Lymphoma | Rituximab Adriamycin Bleomycin Vinblastine Dacarbazine (DT... | 16 Years - | M.D. Anderson Cancer Center | |
| RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease | NCT00002462 | Lymphoma | bleomycin sulfa... doxorubicin hyd... mechlorethamine... prednisone procarbazine hy... vinblastine sul... vincristine sul... low-LET cobalt-... low-LET photon ... radiation thera... | 15 Years - 70 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma | NCT00041210 | Lymphoma | bleomycin sulfa... ABVD regimen Stanford V regi... dacarbazine doxorubicin hyd... etoposide mechlorethamine... prednisone vinblastine sul... vincristine sul... radiation thera... | 18 Years - 60 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma | NCT01026220 | Childhood Nodul... Stage III Child... Stage IV Childh... | bleomycin sulfa... doxorubicin hyd... liposomal vincr... vinorelbine tar... cyclophosphamid... etoposide phosp... prednisone filgrastim ifosfamide | - 21 Years | Children's Oncology Group | |
| Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma | NCT00379041 | Lymphoma | bleomycin sulfa... doxorubicin hyd... mechlorethamine... prednisone procarbazine hy... vinblastine sul... vincristine sul... radiation thera... | 15 Years - 70 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease | NCT00002462 | Lymphoma | bleomycin sulfa... doxorubicin hyd... mechlorethamine... prednisone procarbazine hy... vinblastine sul... vincristine sul... low-LET cobalt-... low-LET photon ... radiation thera... | 15 Years - 70 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors | NCT00453232 | Extragonadal Ge... Teratoma Testicular Germ... | bleomycin sulfa... pegfilgrastim cisplatin etoposide | 18 Years - 40 Years | National Cancer Institute (NCI) | |
| Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma | NCT00678327 | Lymphoma | bleomycin sulfa... filgrastim pegfilgrastim cyclophosphamid... dacarbazine doxorubicin hyd... etoposide prednisolone procarbazine hy... vinblastine sul... vincristine sul... | 18 Years - 100 Years | University College, London | |
| Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma | NCT01132807 | Lymphoma | Bleomycin Sulfa... Doxorubicin Hyd... Procarbazine Hy... Vinblastine Sul... Dacarbazine Cyclophosphamid... Etoposide phosp... prednisone Radiation Thera... Fludeoxyglucose... computed tomogr... Positron Emissi... | 18 Years - 60 Years | Alliance for Clinical Trials in Oncology | |
| Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma | NCT00005867 | Lymphoma | bleomycin sulfa... CHOP regimen cyclophosphamid... doxorubicin hyd... etoposide mitoxantrone hy... prednisolone vincristine sul... | 18 Years - 59 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease | NCT00005578 | Cardiac Toxicit... Lymphoma | bleomycin sulfa... filgrastim cyclophosphamid... dexrazoxane hyd... doxorubicin hyd... etoposide prednisone vincristine sul... radiation thera... | - 21 Years | Children's Oncology Group | |
| Radiation Therapy and Chemotherapy in Treating Patients With Hodgkin's Disease | NCT00002561 | Hodgkin Lymphom... | bleomycin sulfa... dacarbazine doxorubicin hyd... vinblastine radiation thera... | 16 Years - | Canadian Cancer Trials Group | |
| Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma | NCT00041210 | Lymphoma | bleomycin sulfa... ABVD regimen Stanford V regi... dacarbazine doxorubicin hyd... etoposide mechlorethamine... prednisone vinblastine sul... vincristine sul... radiation thera... | 18 Years - 60 Years | National Cancer Institute (NCI) | |
| A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma. | NCT00002093 | Sarcoma, Kaposi HIV Infections | Daunorubicin (l... Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... | 18 Years - | NIH AIDS Clinical Trials Information Service | |
| Rituximab and ABVD for Hodgkin's Patients | NCT00504504 | Lymphoma | Rituximab Adriamycin Bleomycin Vinblastine Dacarbazine (DT... | 16 Years - | M.D. Anderson Cancer Center | |
| Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma | NCT00002715 | Lymphoma | Bleomycin sulfa... Stanford V regi... Doxorubicin hyd... Etoposide Mechlorethamine... Prednisone Vinblastine Vincristine sul... | 18 Years - 60 Years | Stanford University | |
| Radiation Therapy With or Without Chemotherapy After Surgery in Treating Patients With Stage IB or Stage IIA Cervical Cancer | NCT00003209 | Cervical Cancer | bleomycin sulfa... cisplatin fluorouracil ifosfamide methotrexate mitomycin C vinblastine sul... vindesine radiation thera... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS | NCT00001059 | Sarcoma, Kaposi HIV Infections | Doxorubicin hyd... Filgrastim Bleomycin sulfa... Vincristine sul... | 18 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease | NCT00025259 | Childhood Lymph... Childhood Mixed... Childhood Nodul... Childhood Nodul... Stage I Childho... Stage II Childh... Stage III Child... Stage IV Childh... | Bleomycin Sulfa... Cisplatin Cyclophosphamid... Cytarabine Dexamethasone Doxorubicin Hyd... Etoposide Filgrastim Involved-Field ... Prednisone Vincristine Sul... | - 21 Years | Children's Oncology Group | |
| SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant | NCT00002657 | Lymphoma Multiple Myelom... | bleomycin sulfa... recombinant int... cyclophosphamid... cytarabine doxorubicin hyd... etoposide methotrexate prednisone vincristine sul... conventional su... radiation thera... | 15 Years - | SWOG Cancer Research Network | |
| Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma | NCT00000689 | Lymphoma, Non-H... HIV Infections | Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Cyclophosphamid... Methotrexate Cytarabine Leucovorin calc... Sargramostim Dexamethasone | 13 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma | NCT00000681 | Sarcoma, Kaposi HIV Infections | Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Zidovudine Sargramostim | 14 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors | NCT00003811 | Childhood Germ ... Drug/Agent Toxi... Extragonadal Ge... Ovarian Cancer | bleomycin sulfa... amifostine trih... cisplatin etoposide conventional su... | - 14 Years | Children's Oncology Group | |
| A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma | NCT00000658 | Lymphoma, Non-H... HIV Infections | Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Cyclophosphamid... Allopurinol Methotrexate Cytarabine Leucovorin calc... Sargramostim Dexamethasone | 12 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Combination Chemotherapy and Rituximab in Treating Patients With Primary Mediastinal Diffuse Large B-Cell Lymphoma | NCT00689845 | Lymphoma | bleomycin sulfa... filgrastim rituximab cyclophosphamid... cytarabine doxorubicin hyd... etoposide phosp... ifosfamide methotrexate prednisolone prednisone vincristine sul... vindesine | 18 Years - | National Cancer Institute (NCI) | |
| Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors | NCT00274950 | Childhood Germ ... Extragonadal Ge... Ovarian Cancer | bleomycin sulfa... carboplatin cisplatin etoposide ifosfamide vinblastine sul... adjuvant therap... conventional su... | - 17 Years | National Cancer Institute (NCI) | |
| Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma | NCT00002105 | Sarcoma, Kaposi HIV Infections | Doxorubicin hyd... Bleomycin sulfa... Vincristine sul... | 18 Years - | NIH AIDS Clinical Trials Information Service | |
| Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma | NCT00005584 | Lymphoma | bleomycin sulfa... ABVD regimen BEACOPP regimen epirubicin hydr... prednisone vinblastine sul... radiation thera... | 15 Years - 70 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors | NCT00053352 | Childhood Embry... Childhood Extra... Childhood Extra... Childhood Malig... Childhood Malig... Childhood Terat... Ovarian Embryon... Ovarian Yolk Sa... Stage II Malign... Stage IIA Ovari... Stage IIB Ovari... Stage IIC Ovari... Stage III Malig... Stage IIIA Ovar... Stage IIIB Ovar... Stage IIIC Ovar... Testicular Chor... Testicular Embr... | conventional su... cisplatin etoposide bleomycin sulfa... laboratory biom... | - 21 Years | Children's Oncology Group | |
| Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease | NCT00002827 | Cardiac Toxicit... Lymphoma | bleomycin sulfa... filgrastim dexrazoxane hyd... doxorubicin hyd... etoposide vincristine sul... low-LET cobalt-... low-LET electro... low-LET photon ... | - 21 Years | Children's Oncology Group | |
| Combination Chemotherapy in Treating Men With Germ Cell Cancer | NCT00003643 | Extragonadal Ge... Teratoma Testicular Germ... | bleomycin sulfa... filgrastim cisplatin etoposide paclitaxel | 16 Years - 50 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testicles | NCT00324298 | Drug/Agent Toxi... Testicular Germ... | bleomycin sulfa... cisplatin etoposide management of t... | 18 Years - 50 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease | NCT00004010 | Lymphoma | bleomycin sulfa... filgrastim ABVD regimen cyclophosphamid... dacarbazine doxorubicin hyd... etoposide prednisone procarbazine hy... vinblastine sul... vincristine sul... radiation thera... | - 21 Years | Children's Oncology Group | |
| Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma | NCT00920153 | Lymphoma | bleomycin sulfa... ABVD regimen carmustine cisplatin cytarabine dacarbazine dexamethasone doxorubicin hyd... etoposide gemcitabine hyd... ifosfamide melphalan methylprednisol... mitoguazone vincristine sul... vindesine vinorelbine tar... allogeneic hema... autologous hema... | 18 Years - 65 Years | French Innovative Leukemia Organisation | |
| Rituximab and Combination Chemotherapy With or Without Bleomycin Sulfate in Treating Patients With Primary Mediastinal Large B-Cell Lymphoma | NCT00983944 | Lymphoma | bleomycin sulfa... rituximab EPOCH regimen cyclophosphamid... doxorubicin hyd... etoposide prednisone vincristine sul... | 10 Years - | Ohio State University Comprehensive Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
